Tortugas Neuroscience is a clinical-stage biotechnology company based in Framingham, Massachusetts. It focuses on developing potential treatments for major neurology and neuropsychiatric disorders, including schizophrenia, tinnitus, focal epilepsy, and reversible encephalopathies. The company's pipeline includes assets licensed from Eisai and Hansoh Pharmaceutical, with a focus on small molecules with de-risked mechanisms of action.
1
Round
5
Tags
Apr 21, 2026
Latest raise
Funding activity · 1 round
Apr 21, 2026
$106M
Series A
Led by AN Venture Partners
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
